Skip to main content

Table 1 Demographics of Patients

From: Relationship between plasma Atherogenic index and final pathology of Bosniak III-IV renal masses: a retrospective, single-center study

Age (year)

median (min-max)

61 (33–84)

Gender (n, %)

Male

109 (64.5%)

Female (n, %)

60 (35.5%)

Side (n, %)

Right (n, %)

84 (49.7%)

Left (n, %)

85 (50.3%)

Body Mass Index (kg/m2)

mean ± SD

29.00 ± 4.28

Tumour Size (cm)

median (min-max)

6.5 (2–18)

Tumour Localisation (n, %)

Lower Pole

26 (15.4%)

Middle Pole

97 (57.4%)

Upper Pole

46 (27.2%)

Tumour Type (n, %)

Clear Cell

114 (67.5%)

Chromophobe Cell

16 (9.5%)

Papillary

15 (8.9%)

Angiomyolipoma

11 (6.5%)

Oncocytoma

13 (7.7%)

Malignancy (n, %)

Malign

145 (85.8%)

Benign

24 (14.2%)

Fuhrman Grade (n, %)

Grade 2

43 (33.3%)

Grade 3

71 (55.0%)

Grade 4

15 (11.6%)

Tumour Stage (n, %)

T1a

24 (16.7%)

T1b

36 (25.0%)

T2a

16 (11.1%)

T2b

6 (4.2%)

T3a

46 (31.9%)

T3b

11 (7.6%)

T4

5 (3.5%)

Smoking Status (n, %)

Exist

116 (68.6%)

None

53 (31.4%)

Diabetes Mellitus (n, %)

Exist

67 (39.6%)

None

102 (60.4%)

Hypertension (n, %)

Exist

105 (62.1%)

None

64 (37.9%)

Triglyceride Value [mg/dl]

median (min-max)

145 (68–1019)

HDL-Cholesterol Value [mg/dl]

mean ± SD

41.12 ± 11.94

Plasma Atherogenic Index Value

median (min-max)

0.53 (0.15–1.58)